JVMAX | MCVAX | JVMAX / MCVAX | |
Total Expense Ratio | 1.12 | 1.20 | 93% |
Annual Report Gross Expense Ratio | 1.13 | 1.20 | 94% |
Fund Existence | 28 years | 11 years | - |
Gain YTD | -1.298 | 1.989 | -65% |
Front Load | 5% | 6% | 91% |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 21.1B | 1.07B | 1,968% |
Annual Yield % from dividends | 0.61 | 1.08 | 57% |
Returns for 1 year | -9.43 | -4.31 | 219% |
Returns for 3 years | -3.39 | -9.64 | 35% |
Returns for 5 years | 84.10 | 49.63 | 169% |
Returns for 10 years | 28.12 | -1.19 | -2,354% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
USCI | 74.13 | 0.98 | +1.34% |
United States Commodity Index | |||
QTAP | 38.39 | 0.28 | +0.74% |
Innovator Growth-100 Acltd Ps ETF™ April | |||
CEE | 14.25 | 0.07 | +0.49% |
Central and Eastern Europe Fund (The) | |||
XBIL | 50.02 | 0.01 | +0.02% |
US Treasury 6 Month Bill ETF | |||
JMBS | 45.04 | -0.16 | -0.35% |
Janus Henderson Mortgage-Backed Sec ETF |